Atea Pharmaceuticals, Inc.

NASDAQ:AVIR

3.35 (USD) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018
Operating Activities:
Net Income -135.956-115.909121.19-10.947-14.034-9.064
Depreciation & Amortization 0.4160.260.0290.0190.0170.017
Deferred Income Tax -48.5590-29.39-13.798-0.5010
Stock Based Compensation 49.42846.71839.6217.4570.6240.414
Change In Working Capital 16.163-46.586-247.845300.2050.5790.725
Accounts Receivables 000-5.81500
Inventory 0005.14100
Accounts Payables 1.701-1.98310.289-0.4880.157-0.09
Other Working Capital 14.462-44.603-258.134301.3670.4220.815
Other Non Cash Items 33.113-5.46529.3913.7980.5010.538
Operating Cash Flow -85.395-120.982-87.005296.734-12.814-7.908
Investing Activities:
Investments In Property Plant And Equipment 0-1.943-0.004-0.026-0.002-0.012
Acquisitions Net 00.4530000
Purchases Of Investments -562.362-545.3520000
Sales Maturities Of Investments 602.66591.8850000
Other Investing Activites 0.04-0.4530000
Investing Cash Flow 40.303-455.41-0.004-0.026-0.002-0.012
Financing Activities:
Debt Repayment 000000
Common Stock Issued 0.2570.231.465317.632-0.0150.124
Common Stock Repurchased 000000
Dividends Paid 000000
Other Financing Activities 00.140.001214.116-0.01527.359
Financing Cash Flow 0.2570.371.465531.748-0.01527.483
Other Information:
Effect Of Forex Changes On Cash 0.19800000
Net Change In Cash -44.637-576.022-85.544828.456-12.83119.563
Cash At End Of Period 143.823188.658764.68850.22421.76834.599